INVO Bioscience, Inc. (INVO) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed on November 13, 2023, by INVO Bioscience, Inc. (a Nevada corporation), serves to announce the issuance of a press release regarding financial results for the period ended September 30, 2023. The company is listed on The Nasdaq Stock Market LLC under the symbol "INVO."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No material changes versus the prior comparable period are described in the body of this filing. The document solely acts as a notification that results for the period ended September 30, 2023, have been released.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 13, 2023) for actual financial figures and operational updates.
- Verify the specific revenue and net loss figures for the quarter ended September 30, 2023, as they are not present in this summary document.
- Check for any forward-looking statements or updated guidance included in the referenced press release.
- Confirm the company's cash position and runway based on the detailed financial statements referenced in the press release.